Corrigendum to "Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade" [Journal of Controlled Release 332 (2021) 194-209]

Affiliations

• ¹ Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China.
• ² Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 130022 Changchun, China; University of Science and Technology of China, Hefei, Anhui 230026, China.
• ³ Institutes of Biological Sciences, Zhongshan-Xuhui Hospital, Fudan University, Shanghai 200032, China.
• ⁴ School of medicine, University of Electronic Science and Technology of China, 610054 Chengdu, Sichuan, China.
• ⁵ Research Core Facility, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China.
• ⁶ State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China.
• ⁷ Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, 100142 Beijing, China.
• ⁸ Conmed Biosciences Inc, 610200 Chengdu, Sichuan, China.
• ⁹ College of Pharmacy and Biological Engineering, Chengdu University, 610106 Chengdu, Sichuan, China.
• ¹⁰ The National Engineering Laboratory for Anti-Tumor Protein Therapeutics, Beijing Key Laboratory for Protein Therapeutics, Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing, China.
• ¹¹ Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China. Electronic address: [email protected].